ISSN 0975-3583
 

Journal of Cardiovascular Disease Research



    EFFECT OF MIFEPRISTONE ON UTERINE FIBROIDS- COMPARATIVE STUDY


    Vasantha Kumari ,DGO(obs&gyn),Ramya V A, Rajapriya V
    JCDR. 2024: 129-137

    Abstract

    INTRODUCTION : Mifepristone (RU 486) is a progesterone receptor modulator with antagonistic properties. It binds strongly to endometrial progesterone receptors, minimally to estrogen receptors, and upregulates androgen receptors. In a placebo-controlled trial low dose mifepristone (RU 486) has been shown to decrease myoma size as well as symptoms. An increase in androgen receptors also contributes to antiproliferative effects. Mifepristone also delays or inhibits ovulation, which may produce amenorrhoea. Direct suppressive effects on endometrial vasculature as well as on reducing stromal vascular endothelial growth factor (VEGF) have also been suggested for reducing menstrual blood loss.

    Description

    .

    » PDF

    Volume & Issue

    Volume 15 Issue 8

    Keywords